Long-term outcomes of IL-2R antibody vs antithymocyte globulin for induction therapy in kidney transplantation

被引：0
|
作者：
Burke, George W., III [1 ]
Ciancio, Gaetano [1 ]
机构：
[1] Univ Miami, Miller Sch Med, Dept Surg, Div Transplantat, Miami, FL 33101 USA
来源：
NATURE CLINICAL PRACTICE NEPHROLOGY | 2007年 / 3卷 / 03期
关键词：
anti-IL-2R antibody; antithymocyte globulin; chronic rejection; graft survival; kidney transplantation;
D O I：
10.1038/ncpneph0393
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：134 / 135
页数：2
相关论文
共 50 条
  • [1] Long-term outcomes of IL-2R antibody vs antithymocyte globulin for induction therapy in kidney transplantation
    George W Burke
    Gaetano Ciancio
    Nature Clinical Practice Nephrology, 2007, 3 : 134 - 135
  • [2] Short-term versus long-term induction therapy with antithymocyte globulin in orthotopic liver transplantation
    Soliman, Thomas
    Hetz, Hubert
    Burghuber, Christoph
    Gyoeri, Georg
    Silberhumer, Gerd
    Steininger, Rudolf
    Muehlbacher, Ferdinand
    Berlakovich, Gabriela A.
    TRANSPLANT INTERNATIONAL, 2007, 20 (05) : 447 - 452
  • [3] Limited dose monoclonal IL-2R antibody induction protocol after primary kidney transplantation
    Ahsan, N
    Holman, MJ
    Jarowenko, MV
    Razzaque, MS
    Yang, HC
    AMERICAN JOURNAL OF TRANSPLANTATION, 2002, 2 (06) : 568 - 573
  • [4] IL-2r antibody induction with delayed Neoral therapy.
    Henry, ML
    Pelletier, RP
    Elkhammas, EA
    Bumgardner, GL
    Davies, EA
    Ferguson, RM
    TRANSPLANTATION, 1999, 67 (09) : S619 - S619
  • [5] Combined Induction Therapy with Rabbit Antithymocyte Globulin (rATG) and Rituximab (RTX) in Highly Sensitized Kidney Recipients: Long-Term Outcomes.
    Laftavi, M.
    Patel, S.
    Kohli, R.
    Zachariah, M.
    Feng, L.
    Said, M.
    Dayton, M.
    Pankewycz, O.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2013, 13 : 427 - 427
  • [6] Rabbit antithymocyte globulin induction therapy for lung transplantation does not affect long-term allograft function or survival
    Hartwig, M. G.
    Snyder, L. D.
    Appel, J. Z.
    Simsir, S.
    Lin, S. S.
    Palmer, S. M.
    Davis, R. D.
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2005, 24 (02): : S81 - S82
  • [7] Long-term results of rabbit antithymocyte globulin and basiliximab induction
    Brennan, Daniel C.
    Schnitzler, Mark A.
    NEW ENGLAND JOURNAL OF MEDICINE, 2008, 359 (16): : 1736 - 1738
  • [8] Decreased Long-Term Survival with Antithymocyte Globulin Induction in Elderly Kidney Transplant Recipients.
    Bajjoka, I.
    Yaldo, A.
    Crombez, C.
    Abouljoud, M.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2018, 18 : 329 - 329
  • [9] Basiliximab or Antithymocyte Globulin for Induction Therapy in Kidney Transplantation: A Meta-analysis
    Liu, Y.
    Zhou, P.
    Han, M.
    Xue, C-B
    Hu, X-P
    Li, C.
    TRANSPLANTATION PROCEEDINGS, 2010, 42 (05) : 1667 - 1670
  • [10] Long term risks of antibody induction therapy in kidney transplantation.
    Meier-Kriesche, HU
    Schold, JD
    Srinivas, TR
    Womer, K
    Hemming, AW
    Kaplan, B
    AMERICAN JOURNAL OF TRANSPLANTATION, 2004, 4 : 264 - 264
12345